<DOC>
	<DOCNO>NCT00498693</DOCNO>
	<brief_summary>Specific Aim 1 . To identify specific SNPs HIF-1 gene relate cardiovascular disease OSA patient ( CVD-OSA ) 2 . To assay functional activity high risk SNPs HIF-1 transcription VEGF gene 3 . To confirm serum level VEGF CVD-OSA patient high risk SNPs HIF-1 high CVD-OSA patient without</brief_summary>
	<brief_title>Hypoxia Inducible factor1-Alpha Genetic Polymorphism Obstructive Sleep Apnea</brief_title>
	<detailed_description>Obstructive sleep apnea syndrome ( OSAS ) characterize recurrent collapse upper airway sleep result hypoxia sleep fragmentation . The repeated episode hypoxia sympathetic hyperactivity result cardiovascular complication , include atherosclerosis , hypertension , coronary artery disease heart failure . Our data show among 309 consecutively-admitted OSA patient , 54 % patient cardiovascular disease . The hypoxia OSA characterize chronic intermittent , lead sophisticated adaptive mechanism , like activation transcriptional factor critical signaling pathway . HIF-1 central component transcriptional factor involve hypoxia-induced transcription specific gene . There two subunit HIF-1 transcription factor , interact consensus hypoxia response element target gene . The HIF-1 alpha activity regulate proline hydroxylation modification ubiquitination , oxygen-tension dependent . HIF-1 alpha target gene encode protein increase oxygen delivery , vascular endothelial growth factor ( VEGF ) . Our oligo-microarray study show HIF VEGF expression OSA patient 1.3 time control group , decrease 46 % 57 % respectively one-month CPAP treatment . HIF-1 alpha polymorphism could result increase HIF-1 alpha activity microvessel density . In clinical observation , HIF-1 polymorphism report associated high altitude adaptation , formation coronary collateral CAD phenotype cancer . These finding possibly explain effect HIF modulation VEGF . Several genetic polymorphism report associated OSA , include TNF alpha , angiotensin convert enzyme haptoglobin . Only hepatoglobin phenotype prove risk factor cardiovascular disease OSA . In study , patient number less suggested . Therefore , study , hypothesize HIF-1 gene polymorphism associate cardiovascular disease OSA . And use large-scale study population ( 1000 OSA patient ) , examine region HIF-1 alpha detect single-nucleotide polymorphism ( SNPs ) , evaluate pattern linkage disequilibrium compose haplotype gene , perform association study OSA patient without cardiovascular disease achieve follow 3 objective : ( 1 ) To identify specific SNPs HIF-1 alpha gene related cardiovascular disease OSA patient ( CVD-OSA ) . ( 2 ) To assay functional activity high risk SNPs HIF-1 alpha transcription VEGF gene . ( 3 ) To confirm serum level VEGF CVD-OSA patient high risk SNPs HIF-1 high CVD-OSA patient without . The finding expect stratify risk OSA patient specific outcome , response specific therapy .</detailed_description>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Severe obstructive sleep apnea ( AHI &gt; =30/hr ) age , sex , BMI match control subject Patients exclude : ( 1 ) refuse participate study , ( 2 ) severe obstructive pulmonary disease active neurological event , ( 3 ) enrol study time</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
</DOC>